Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Baxter InternationalBAX +3.37%60 3-1 Month Momentum % is 15.86% as of Jul. 27, 2026. GuruFocus rates BAX with a GF Score™ of 60/100 and a GF Value™ of $34.41 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 846 Medical Devices & Instruments companies, Baxter International ranks better than 88.53% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-07-27), Baxter International's 3-1 Month Momentum % is 15.86%.
The industry rank for Baxter International's 3-1 Month Momentum % or its related term are showing as below:
BAX's 3-1 Month Momentum % is ranked better than 88.53% of 846
companies
in the Medical Devices & Instruments industry
Industry Median: -9.14
vs BAX: 15.86
Baxter International (NYSE:BAX) 3-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Baxter International 3-1 Month Momentum % Related Terms
BAX vs ALGN, SOLV, COO: 3-1 Month Momentum % Comparison
For the Medical Instruments & Supplies subindustry, Baxter International's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Baxter International 3-1 Month Momentum % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Baxter International's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Baxter International's 3-1 Month Momentum % falls into.
Baxter International (NYSE:BAX) 3-1 Month Momentum % Calculation
3-1 Month Momentum % is calculated as following:
3-1 Month Momentum %
=
( Price 1-month ago
/
Price 3-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Baxter International (BAX) has a 3-1 Month Momentum % of 15.86% as of Jul. 27, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Baxter International and its competitors. According to the industry distribution chart, Baxter International ranks #97 out of 846 companies in the Medical Devices & Instruments industry, placing it in the top 11.5%.
Is Baxter International's 3-1 Month Momentum % too high?
Baxter International's current 3-1 Month Momentum % is 15.86%. Based on the distribution chart, Baxter International ranks #97 out of 846 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Baxter International has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Baxter International's 3-1 Month Momentum % compare to ALGN and SOLV?
According to the Medical Devices & Instruments industry distribution chart, Baxter International ranks #97 out of 846 companies for 3-1 Month Momentum %. This places Baxter International in the top 12% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Medical Devices & Instruments company?
A good 3-1 Month Momentum % depends on the Medical Devices & Instruments industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Baxter International and its competitors. Baxter International's current 3-1 Month Momentum % is 15.86%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baxter International stock overvalued right now?
Based on GuruFocus' analysis, Baxter International (BAX) is currently considered Possible Value Trap. The stock's GF Value™ is $34.41, compared to a current price of $22.40 — trading 34.9% below its estimated fair value. The current 3-1 Month Momentum % is 15.86%. Baxter International's overall GF Score™ is 60/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Baxter International (BAX), the current 3-1 Month Momentum % is 15.86% as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Baxter International (BAX) Overvalued in 2026?
Based on GuruFocus' analysis, Baxter International stock appears to be undervalued.
The current stock price of $22.40 is trading 34.9% below its estimated GF Value™ of $34.41.
GuruFocus considers Baxter International to be Possible Value Trap.
Key valuation signals for BAX:
3-1 Month Momentum %: 15.86%
GF Value™: $34.41 vs. price of $22.40 (34.9% below fair value)
No single metric tells the full story. See the BAX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
60GF Score
Get the complete analysis for BAX
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BAX has been successfully added to your 
